Speaker: Dr. Aalok Kumar, MD, MHSc, FRCPC, Medical Oncologist, BC Cancer Surrey,
Conflicts of Interest: Direct finacial payments incl. honoraria: AZ, GSK, Pzfier, Merck, Mylan, Roche ---Speaker's bureau/ad boards: AZ, GSK, Pzfier, Merck, Roche

Program Learning objectives:
Upon completion of this program participants will have:

• Enhanced understanding on what MDS/AML are, and how they develop
• Expanded knowledge on how PARPi use can increase the risk of MDS/AML
• Ability to discuss optimal duration of therapy on PARPi